Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant

dc.contributor.authorAmin, H
dc.contributor.authorJadavji, T
dc.contributor.authorSauve, R
dc.contributor.authorGill, J
dc.date.accessioned2018-09-27T12:33:16Z
dc.date.available2018-09-27T12:33:16Z
dc.date.issued1990-01-01
dc.date.updated2018-09-27T12:33:16Z
dc.description.abstractThe first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days was given without adverse clinical or toxic effects. The patient has remained well following discharge from hospital.
dc.description.versionPeer Reviewed
dc.identifier.citationH Amin, T Jadavji, R Sauve, and J Gill, “Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant,” Canadian Journal of Infectious Diseases, vol. 1, no. 1, pp. 28-30, 1990. doi:10.1155/1990/917057
dc.identifier.doihttps://doi.org/10.1155/1990/917057
dc.identifier.urihttp://hdl.handle.net/1880/108666
dc.identifier.urihttps://doi.org/10.11575/PRISM/44738
dc.language.rfc3066en
dc.rights.holderCopyright © 1990 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleUse of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CJIDMM.1990.917057.pdf
Size:
750.96 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: